Where Does Wall Street Think FibroGen Inc (FGEN) Stock Will Go?

InvestorsObserver is giving FibroGen Inc (FGEN) an Analyst Rating Rank of 2, meaning FGEN is ranked higher by analysts than 2% of stocks. The average price target for FGEN is $2.166 and analyst’s rate the stock as a Hold.

Wall Street analysts are rating FGEN a Hold today. Find out what this means to you and get the rest of the rankings on FGEN!

See Full FGEN Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With FibroGen Inc Stock Today?

FibroGen Inc (FGEN) stock has gained 3.38% while the S&P 500 is down -1.36% as of 1:44 PM on Tuesday, Sep 26. FGEN is up $0.03 from the previous closing price of $0.84 on volume of 3,120,418 shares. Over the past year the S&P 500 has gained 17.05% while FGEN is down -92.85%. FGEN lost -$3.39 per share the over the last 12 months. Click Here to get the full Stock Report for FibroGen Inc stock.